Coronavirus: GSK chief urges drug firms to work together to develop vaccines April 15, 2020 The chief executive of pharmaceuticals giant Glaxosmithkline (GSK) has urged companies to join together to speed the development of a coronavirus vaccine, warning that the world will need more than one treatment for the disease. Emma Walmsley’s words came after the firm announced it had partnered with French drugmaker Sanofi to make a vaccine. Clinical [...]
GSK partners with Sanofi to develop coronavirus vaccine April 14, 2020 Pharmaceuticals giant Glaxosmithkline (GSK) has joined forces with French drugmaker Sanofi to develop a vaccine for the coronavirus disease. The two firms said that they were planning to begin clinical trials for the new treatment in the second half of this year. If successful, it is hoped that the vaccine would become available in the [...]
Pharma giant GSK takes $250m stake in firm to develop coronavirus vaccine April 7, 2020 Pharmaceuticals giant Glaxosmithkline (GSK) has taken a $250m (£202.7m) stake in an American biotech company in a collaborative effort to make a vaccine for Covid-19. Vir Biotechnology, of which GSK now owns a 6 per cent stake, specialises in the treatment of severe infectious diseases, and is looking to develop an antibody treatment for the [...]
Unilever acquires Horlicks brand in India in £397m deal April 1, 2020 Consumer goods giant Unilever has today completed the acquisition of Horlicks and other Glaxosmithkline brands in a £397m deal. The deal will allow Unilever to use the Horlicks brand rights and other GSK Consumer Healthcare nutrition brands in predominantly Asian markets. The company’s listed subsidiary in India, Hindustan Unilever Limited (Hul) also announced today that [...]
GSK falls short of forecasts as firm prepares to split February 5, 2020 Multinational drug firm Glaxosmithkline (GSK) saw a small rise in operating profit and earnings in 2019 as the firm announced it had begun its planned split into two companies following its venture with Pfizer. However, earnings per share fell short of analyst expectations at 123.9p, below consensus estimates of 125p. Pressure on the price of [...]
Glaxosmithkline posts third-quarter sales growth after Pfizer purchase October 30, 2019 Glaxosmithkline have reported group sales of £9.4bn for the third quarter, with total operating profits of £2.1m, compared with £1.9m for the same period in 2018. The drug manufacturer raised its forecast for 2019, saying that it now expected profits to be flat compared to last year, up from a previous estimated of a three [...]
GSK continues pharmaceuticals push with $1.1bn vaccines sale October 21, 2019 Glaxosmithkline (GSK) has today announced the sale of two travel vaccines worth up to $1.1bn (£846.9m) to Bavarian Nordic, continuing its push into the cancer drug market. The sales of Rabipur, an anti-rabies drug, and Encipur, which is used to prevent encephalitis, to the Denmark-based biotech firm, will include an upfront payment of €301m (£258.5m), [...]
GSK eyes former Astrazeneca CFO for empty chair July 14, 2019 Drugmaker Glaxosmithkline is set to announce the former finance boss of Astrazeneca as its new chair to oversee the breakup of the business. GSK is preparing to appoint Jonathan Symonds as its new non-executive chair, Sky News reported earlier. Read more: GSK to split as it forms £9.8bn consumer health venture with Pfizer The announcement [...]
FTSE 100 bosses to meet President Donald Trump during UK state visit May 31, 2019 A group of FTSE 100 chiefs will meet US President Donald Trump during his state visit to the UK next week, Sky News has reported, along with the heads of various US companies. Read more: European stock markets bleed red as Trump takes trade war to Mexico The bosses of Barclays, National Grid, BAE Systems, [...]
UK’s biggest companies pull away as profits for rest of pack plunge May 8, 2019 Average profits at the UK’s 40 biggest companies rose by 11 per cent in the first quarter of the year while those outside the group saw a fall of 18 per cent, new analysis has shown, laying bare a stark division in the fortunes of British companies. Read more: 'Zombie firms' dragging down UK economy, [...]